Cargando…
RIPK1 deficiency prevents thymic NK1.1 expression and subsequent iNKT cell development
Receptor Interacting Protein Kinase 1 (RIPK1) and caspase-8 (Casp8) jointly orchestrate apoptosis, a key mechanism for eliminating developing T cells which have autoreactive or improperly arranged T cell receptors. Mutations in the scaffolding domain of Ripk1 gene have been identified in humans with...
Autores principales: | Hägglöf, Thomas, Parthasarathy, Raksha, Liendo, Nathaniel, Dudley, Elizabeth A., Leadbetter, Elizabeth A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642909/ https://www.ncbi.nlm.nih.gov/pubmed/37965338 http://dx.doi.org/10.3389/fimmu.2023.1103591 |
Ejemplares similares
-
22511 Glycolipid-loaded nanoparticles harness iNKT cells for tumor immunotherapy
por: Shute, Travis, et al.
Publicado: (2021) -
iNKT Cells Suppress Pathogenic NK1.1(+)CD8(+) T Cells in DSS-Induced Colitis
por: Lee, Sung Won, et al.
Publicado: (2018) -
Developmental Dynamics of Post-Selection Thymic DN iNKT
por: Yassai, Maryam, et al.
Publicado: (2012) -
Identification of an IL-17–producing NK1.1(neg) iNKT cell population involved in airway neutrophilia
por: Michel, Marie-Laure, et al.
Publicado: (2007) -
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
por: McNerney, Kevin O., et al.
Publicado: (2020)